DK1321471T3 - Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf - Google Patents
Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte herafInfo
- Publication number
- DK1321471T3 DK1321471T3 DK03290605T DK03290605T DK1321471T3 DK 1321471 T3 DK1321471 T3 DK 1321471T3 DK 03290605 T DK03290605 T DK 03290605T DK 03290605 T DK03290605 T DK 03290605T DK 1321471 T3 DK1321471 T3 DK 1321471T3
- Authority
- DK
- Denmark
- Prior art keywords
- perindopril
- pharmaceutically acceptable
- acceptable salts
- synthesis procedure
- new synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
- 229960002582 perindopril Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03290605A EP1321471B1 (fr) | 2003-03-12 | 2003-03-12 | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1321471T3 true DK1321471T3 (da) | 2005-08-29 |
Family
ID=8185877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03290605T DK1321471T3 (da) | 2003-03-12 | 2003-03-12 | Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1321471B1 (da) |
| AR (1) | AR043567A1 (da) |
| AT (1) | ATE294814T1 (da) |
| DE (1) | DE60300581T2 (da) |
| DK (1) | DK1321471T3 (da) |
| ES (1) | ES2240919T3 (da) |
| MY (1) | MY135359A (da) |
| PT (1) | PT1321471E (da) |
| SI (1) | SI1321471T1 (da) |
| WO (1) | WO2004083238A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2286393T3 (es) * | 2003-06-30 | 2007-12-01 | Les Laboratoires Servier | Nuevo procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables. |
| SI1367061T1 (sl) * | 2003-06-30 | 2006-04-30 | Servier Lab | Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli |
| ES2271497T3 (es) * | 2003-07-31 | 2007-04-16 | Les Laboratoires Servier | Nuevo procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables. |
| SI1380590T1 (sl) | 2003-08-29 | 2006-12-31 | Servier Lab | Postopek za sintezo perindoprila in njenih farmacevtsko sprejemljivih soli |
| ATE310012T1 (de) | 2003-08-29 | 2005-12-15 | Servier Lab | Verfahren für die synthese von perindopril und seiner pharmazeutisch annehmbaren salzen |
| CA2618561C (en) * | 2005-08-12 | 2014-04-29 | Lek Pharmaceuticals D.D. | A process for the preparation of perindopril erbumine |
| WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
| PH12018502155B1 (en) | 2016-04-20 | 2024-03-27 | Servier Lab | Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ202903A (en) * | 1981-12-29 | 1988-01-08 | Hoechst Ag | 1-- pe pyrrol-2-yl-carboxylic acid derivatives and pharmaceutical compositions |
| FR2807431B1 (fr) * | 2000-04-06 | 2002-07-19 | Adir | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables |
| FR2827860B1 (fr) * | 2001-07-24 | 2004-12-10 | Servier Lab | Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril |
-
2003
- 2003-03-12 DK DK03290605T patent/DK1321471T3/da active
- 2003-03-12 DE DE60300581T patent/DE60300581T2/de not_active Expired - Lifetime
- 2003-03-12 EP EP03290605A patent/EP1321471B1/fr not_active Expired - Lifetime
- 2003-03-12 SI SI200330035T patent/SI1321471T1/xx unknown
- 2003-03-12 AT AT03290605T patent/ATE294814T1/de active
- 2003-03-12 PT PT03290605T patent/PT1321471E/pt unknown
- 2003-03-12 ES ES03290605T patent/ES2240919T3/es not_active Expired - Lifetime
-
2004
- 2004-03-12 MY MYPI20040880A patent/MY135359A/en unknown
- 2004-03-12 AR ARP040100804A patent/AR043567A1/es not_active Application Discontinuation
- 2004-03-12 WO PCT/FR2004/000594 patent/WO2004083238A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004083238A1 (fr) | 2004-09-30 |
| DE60300581T2 (de) | 2006-01-19 |
| EP1321471B1 (fr) | 2005-05-04 |
| EP1321471A1 (fr) | 2003-06-25 |
| MY135359A (en) | 2008-03-31 |
| SI1321471T1 (da) | 2005-08-31 |
| PT1321471E (pt) | 2005-07-29 |
| ATE294814T1 (de) | 2005-05-15 |
| ES2240919T3 (es) | 2005-10-16 |
| DE60300581D1 (de) | 2005-06-09 |
| AR043567A1 (es) | 2005-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1268424T3 (da) | Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte | |
| DK1523488T3 (da) | Nye thiophenglycosidderivater, fremgangsmåder til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| NO20045064L (no) | Indol-, azaindol- og beslektede heterocykliske 4-alkenyl-piperidin-amider | |
| DK1590321T3 (da) | Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf | |
| DK1362864T3 (da) | Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1367061T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1420028T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1556382T3 (da) | 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf | |
| IS7798A (is) | Efnasambönd, lyfjablöndur og aðferðir | |
| IS7424A (is) | Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær | |
| DK1776340T3 (da) | N - (1 H-indolyl) -1 H - indol - 2 - carboxamid-derivater, fremstilling og terapeutisk anvendelse heraf | |
| DK1380590T3 (da) | Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1371659T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1420029T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1380591T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf | |
| DK1422236T3 (da) | Syntesefremgangsmåde for perindopril og farmaceutisk acceptable salte heraf | |
| DK1403275T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1367062T3 (da) | Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1367063T3 (da) | Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1753720T3 (da) | Fremgangsmåde til fremstilling af perindopril og salte deraf | |
| DE60323130D1 (de) | Indolderivaten | |
| DK1403278T3 (da) | Syntesefremgangsmåde for N-[(S)-1-ethoxycarbonylbutyl]-(S)-alanin og anvendelse heraf ved syntesen af perindopril | |
| FR2839024B1 (fr) | Appui-tete rotatif |